Thursday, August 28
09:00 – 09:45
|
Registration |
|
09:45 – 10:00
|
Welcome
Camillo Ribi, Lausanne; Julia Esser-Von Bieren, Epalinges
|
|
Rome
|
||
10:00 – 11:30
|
Plenary 1-3
Sanjiv Luther, Epalinges; Yannick Muller, Lausanne
|
|
Rome
MIX: Fundamental & Clinical Science
|
||
Basis of autoimmune dysregulation
Carola Vinuesa, London
|
||
Resetting autoimmunity in immune-mediated autoimmune disease
Gerhard Krönke, Berlin
|
||
Advances in diagnosis and treatment of inflammatory skin disease
Michel Gilliet, Lausanne
|
||
11:30 – 12:00
|
Coffee break |
|
12:00 – 12:30
|
Plenary 4
Isabelle Arnold Wallén, Zürich; Julia Esser-Von Bieren, Epalinges
|
|
Rome
MIX: Fundamental & Clinical Science
|
||
Modulation of human immunity by T cell cross-reactivity: from commensals to intestinal food antigens
Petra Bacher, Kiel
|
||
12:30 – 14:00
|
Lunch break |
|
12:45 – 13:45
|
Guided poster tour Thursday |
|
St. Moritz B
|
||
13:00 – 13:45
|
Company Symposia 1 |
|
St. Moritz A
|
||
Exploring New Horizons in Hereditary Angioedema (HAE) Treatment: Innovations and Future Perspectives |
||
13:00 – 13:45
|
Company Symposia 2 |
|
Turin AB
|
||
Allergen Immunotherapy (AIT) in children
Sponsors
|
||
14:00 – 15:30
|
Parallel Session 1: Allergy (respiratory)
Milena Sokolowska, Davos; Niki Ubags, Lausanne
|
|
Rome
MIX: Fundamental & Clinical Science
|
||
Epithelial Barrier Theory and the Development of Allergic, Autoimmune and Neuropsychiatric Diseases
Cezmi Akdis, Davos Wolfgang
|
||
Macrophage memory as a driver of type 2 inflammatory diseases
Julia Esser-Von Bieren, Epalinges
|
||
Location matters: defining the architecture of the bronchial wall in health and asthma
Clare Lloyd, London
|
||
14:00 – 15:30
|
Parallel Session 2: Tumor-Immunology
Denarda Dangaj, Lausanne
|
|
St. Moritz A
FUN: Fundamental Science
|
||
Unveiling the Mechanisms of TIL Therapy: Toward Next-Generation Approaches
Alexandre Harari, Lausanne
|
||
Targeting malignant glioma immunomatrix with engineered immune cells
Denis Migliorini, Genève
|
||
Local mechanisms regulating anti-cancer immunity in tumors
Jan Böttcher, Tübingen
|
||
14:00 – 15:30
|
Parallel Session 3: Immune defects
Mike Recher, Basel; Jana Pachlopnik, Zürich
|
|
Turin AB
CLI: Clinical Science
|
||
Human ADA2 deficiency
Isabelle Meyts, Leuven
|
||
BMT in severe immune deficits
Tayfun Güngör, Zürich
|
||
Inborn errors of immunity in inflammatory bowel disease
Holm Uhlig, Oxford
|
||
15:30 – 16:00
|
Coffee break |
|
16:00 – 17:00
|
Short Communication Session – Allergology
Sina Bohnacker, Lausanne; Cezmi Akdis, Davos Wolfgang
|
|
Turin AB
MIX: Fundamental & Clinical Science
|
||
16:00 – 17:00
|
Short Communication Session – Clinical Immunology
Camillo Ribi, Lausanne; Gerhard Krönke, Berlin
|
|
St. Moritz A
MIX: Fundamental & Clinical Science
|
||
17:00 – 17:15
|
Short break |
|
17:15 – 18:15
|
SSAI General Assembly |
|
Rome
|
||
18:15 – 19:00
|
Evening Reception |
|
19:30 – 23:00
|
Congress Dinner |
|